Jerusalem, Jan 13 (IANS) Researchers from Israel, China, the US and Sweden have developed a new targeted therapy for lupus patients, Bar Ilan University in central Israel has said.
The new treatment, published in the Journal of Clinical Investigation, inhibits specific immune cells associated with lupus nephritis. These T-cells affect the kidney by interacting and binding with other cells, much like a key inserts into a lock, Xinhua news agency reported.
To disrupt the damaging process, the researchers developed an antibody that neutralised the T-cells, just like putting glue in the lock to prevent a key from inserting into it.
Lupus is an autoimmune disease in which the body recognises and attacks its own tissues, and can affect many organs.
About half of lupus patients would develop lupus nephritis, an inflammation that can destroy the kidneys.
Some patients don’t respond well to medications, and even when they do, the drugs could bring many side effects, including suppression of the immune system and infections.
–IANS
int/khz/
[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…
[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…
[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…
In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…
[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…
[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…